AD

Ashi Dayal

Active Director Director DIN 07146226
DIN 07146226 First appointment Mar 2015 Primary industry Consumer Goods
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2015
Shareholding value •••• Premium profile

About Ashi Dayal

Data last updated:

Ashi Dayal is a Director at Uas Pharmaceuticals (India) Private Limited (since 2015). The company operates in Consumer Goods. Uas Pharmaceuticals (India) Private Limited reported revenue of ₹1.86 Cr (FY 2019).

DIN 07146226
Primary Designation Director
Industry Consumer Goods
First Appointment 31 Mar 2015
Oldest Company Age 19 yrs
Largest company Uas Pharmaceuticals (India) Private Limited · ₹1.86 Cr (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Mar 20152007₹1.86 Cr (FY 2019)Active

Directorship timeline

Open interactive timeline →
Uas Pharmaceuticals (India) Private Limited
Premium access

Shareholding and investment profile for Ashi Dayal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashi Dayal

Ashi Dayal currently holds 1 directorship: Uas Pharmaceuticals (India) Private Limited (Director, since 31 Mar 2015, revenue ₹1.86 Cr (FY 2019)).

Ashi Dayal was first appointed on 31 Mar 2015 as Director at Uas Pharmaceuticals (India) Private Limited.

The current boards of Ashi Dayal's companies include Ajit Kumar Seth (Uas Pharmaceuticals (India) Private Limited), Anuj Seth (Uas Pharmaceuticals (India) Private Limited), Urvashi Seth (Uas Pharmaceuticals (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available